...
...

vaccine

Next China+1 opportunity is not in pills, but bioprocessing

Pharma
Published on Sept 07, 2026 01:51 pm IST

Moderna stock drops 12% after 177% surge: Here’s what Wall Street says for MRNA

Moderna stock falls 12% after a 177% surge as investors weigh the intismeran cancer vaccine win, future demand, pricing and other cancer trials. (AP Photo/Bill Sikes, File)prnto
Published on Aug 20, 2026 04:02 pm IST

Melanoma trial and mRNA vaccine: Is this the future of cancer treatment?

Moderna shares spiked by a record 177% on Wednesday and Merck's shares climbed nearly 13%.
Published on Aug 28, 2026 12:20 am IST

Moderna shares surge 120% on cancer vaccine results: Why the stock is soaring

Moderna stock surged after its mRNA cancer vaccine showed positive Phase 3 results with Merck’s Keytruda, boosting hopes for a new melanoma treatment. (REUTERS/Dado Ruvic/Illustration/File Photo)
Updated on Aug 19, 2026 11:01 pm IST

Trump's vaccine order sparks backlash: Doctor opposes splitting MMR shot

Trump signs an executive order in the Oval Office calling for the MMR vaccine to be split into three separate shots.
Published on Aug 11, 2026 05:56 am IST